Vaccine List

Acyclovir

Newborns infected with herpes simplex virus (HSV) can be appropriately treated with acyclovir, a drug typically prescribed to adults for the treatment of HSV infections.

Acyclovir’s drug label now includes information for healthcare providers on recommended usage and dosage in newborns up...Read more...

Adacel

(diphtheria, tetanus acellular, and pertussis adult vaccine - also called Tdap) is used to help prevent tetanus, diphtheria, and pertussis in people who are at least 10 years old. Most people in this age group require only one Tdap shot for protection against these diseases.  Adacel vaccine is...Read more...

Afluria

AFLURIA is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B present in the vaccine. AFLURIA is approved for use in persons 6 months of age and older.  AFLURIA is contraindicated in individuals with known...Read more...

ASP3772

In Affinivax’s MAPS vaccine against pneumococcus, proprietary pneumococcal protein antigens enable the potential for an additional immune response to protect against disease due to a broader range of ‘non-vaccine’ pneumococcal serotypes, beyond what is covered by today’s vaccines.

The...Read more...

AV7909 - NuThrax - Anthrax

NuThrax™, anthrax vaccine adsorbed with CPG 7909 adjuvant, in the event of a public health emergency involving Bacillus anthracis.

BARDA Securing Anthrax Immunity For the Elderly (B-SAFE)  This study is designed...Read more...

BEXSERO

BEXSERO is an FDA-approved vaccine to prevent invasive disease caused by Neisseria meningitidis serogroup B.

BEXSERO is approved for use in individuals 10 through 25 years of age.

BEXSERO meningitis B vaccine that can be completed in as fast as 1 month with just 2 doses.

The...Read more...

Boostrix

BOOSTRIX is a vaccine indicated for active booster immunization against tetanus, diphtheria, and pertussis. BOOSTRIX is approved for use as a single dose in individuals 10 years of age and older. A severe allergic reaction after a previous dose of any tetanus toxoid-, diphtheria toxoid-, or...Read more...

BPZE1 (Whooping Cough)

BPZE1 is a live, attenuated form of the pertussis bacterium. BPZE1 is given as a mist into the nose, rather than a shot in the arm. ILiAD Biotechnologies, LLC (ILiAD) is providing the vaccine.

FDA has cleared the Investigational New Drug (IND) application for a Phase 2a BPZE1 study at the...Read more...

Daptacel

DAPTACEL is a vaccine indicated for active immunization against diphtheria, tetanus, and pertussis as a five-dose series in infants and children 6 weeks through 6 years of age (prior to 7th birthday). DAPTACEL is to be administered as a 5 dose series at 2, 4 and 6 months of age (at intervals of...Read more...

Dengvaxia

Dengvaxia® is approved for use in several endemic countries in Latin America and Asia where reducing the human and economic burden of dengue is critical.

The vaccine is currently under priority review by the US Food and Drug Administration (FDA) as it would be considered a significant...Read more...

Egaten

Egaten is currently the only treatment for fascioliasis recommended by the WHO and is on the WHO Model List of Essential Medicines.

Fascioliasis, commonly known as liver fluke infestation, is a neglected tropical disease that currently affects an estimated 2.4 million people worldwide,...Read more...

Engerix-B

ENGERIX-B is a vaccine indicated for immunization against infection caused by all known subtypes of hepatitis B virus. Primary immunization for infants (born of hepatitis B surface antigen [HBsAg]-negative or HBsAg-positive mothers), children (birth through 10 years), and adolescents (aged 11...Read more...

Flu-v

Flu-v is a synthetic universal flu vaccine candidate offering long-lasting protection across a broad spectrum of influenza which could be given to a much broader population.

hVIVO plc, announced positive results for the primary...Read more...

Fluad

FLUAD is a vaccine that helps protect against the flu. FLUAD is for people aged 65 years and older. Vaccination with FLUAD may not protect all people who receive the vaccine.Read more...

Fluarix Quadrivalent

FLUARIX QUADRIVALENT is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. FLUARIX QUADRIVALENT is approved for use in persons aged 3 years and older.Read more...

Flublok

Flublok and Flublok Quadrivalent vaccines are given to people 18 years of age and older to help prevent influenza disease caused by influenza A virus subtypes and influenza type B virus contained in the vaccine. Read more...

Flucelvax

FLUCELVAX QUADRIVALENT is a vaccine that helps protect against influenza (flu). FLUCELVAX is for people aged 4 and older. Vaccination with FLUCELVAX QUADRIVALENT may not protect all people who receive the vaccine.Read more...

Flucelvax Tetra

Flucelvax Tetra will be the first cell-based quadrivalent influenza vaccine (QIVc) available in Europe. The cell-based technology represents one of the most momentous changes in the way influenza vaccines are manufactured since the 1940s.Read more...

Flulaval Quadrivalent

FLULAVAL QUADRIVALENT is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. FLULAVAL QUADRIVALENT is approved for use in persons aged 6 months and older.Read more...

Flumist Quadrivalent

The Advisory Committee on Immunization Practices (ACIP) recommended that FluMist Quadrivalent not be used for the 2016-2017 season. FluMist Quadrivalent is a vaccine that is sprayed into the nose to help protect against influenza. It can be used in children, adolescents, and adults ages 2...Read more...

Fluvirin

FLUVIRIN® (Influenza Virus Vaccine) is an inactivated subunit influenza virus vaccine indicated for active immunization of persons aged 4 years and older against influenza disease caused by influenza virus subtypes A and B included in the vaccine.Read more...

Fluzone

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine. Fluzone Quadrivalent vaccine is given to people 6 months of age and older. Fluzone...Read more...

Fluzone High-Dose

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine. Fluzone High-Dose vaccine is given to people 65 years of age and older...Read more...

Fluzone Intradermal

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine. Fluzone Intradermal Quadrivalent vaccine is given to people 18...Read more...

Fluzone Quadrivalent

Fluzone Quadrivalent, Fluzone Intradermal Quadrivalent, and Fluzone High-Dose vaccines are given to help prevent influenza disease caused by influenza A and B strains contained in each vaccine. Fluzone Quadrivalent vaccine is given to people 6 months of age and older....Read more...

Gardasil

GARDASIL is a vaccine indicated in girls and women 9 through 26 years of age for the prevention of the following diseases caused by Human Papillomavirus (HPV) types included in the vaccine: Cervical, vulvar, vaginal, and anal cancer caused by HPV types 16 and 18, Genital warts (condyloma...Read more...

Gardasil 9

GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) helps protect girls and women ages 9 to 26 against cervical, vaginal, vulvar, and anal cancers and genital warts caused by 9 types of HPV. GARDASIL 9 helps protect boys and men ages 9 to 26 against anal cancer and genital warts...Read more...

Harvoni

HARVONI is a prescription medicine used to treat adults with chronic (lasting a long time) hepatitis C (Hep C) genotype (GT) 1, 4, 5 or 6 infection with or without cirrhosis (compensated). In those with GT 1 and advanced cirrhosis (decompensated) or with GT 1 or 4 with or without cirrhosis (...Read more...

Havrix

HAVRIX is a vaccine indicated for active immunization against disease caused by hepatitis A virus (HAV). HAVRIX is approved for use in persons 12 months of age and older. Primary immunization should be administered at least 2 weeks prior to expected exposure to HAV.Read more...

Hepagam B

HepaGam B® [Hepatitis B Immune Globulin Intravenous (Human)] is an intravenous immune globulin indicated for the following: Prevention of Hepatitis B recurrence following liver transplant in HBsAg-positive liver transplant patients.  Post-exposure prophylaxis...Read more...

HEPLISAV-B

HEPLISAV-B is indicated for the prevention of infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older.

Hepatitis B has a long incubation period. HEPLISAV-B may not prevent hepatitis B infection in individuals who have an unrecognized hepatitis B...Read more...

HydroVax-001 (West Nile)

HydroVax-001 experimental vaccine was discovered and developed by scientists at the Oregon National Primate Research Center at Oregon Health & Science University (OHSU) in Portland.

The scientists were funded with a $7.2 million grant awarded in 2009 from NIAID, part of the National...Read more...

Imovax

Imovax Rabies is a vaccine indicated for pre-exposure and post-exposure prophylaxis against rabies. Imovax Rabies vaccine is approved for use in all age groups.Read more...

Infanrix

INFANRIX is a vaccine indicated for active immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children 6 weeks to 7 years of age (prior to seventh birthday).Read more...

INO-A002 (Zika)

Inovio Technology Platform

Inovio's proprietary platform is leading the way forward for activation immunotherapy.

This one-of-a-kind platform delivers optimized DNA into cells, where it is translated into proteins that activate an individual's immune system to generate a robust...Read more...

Kinrix

A single dose of KINRIX is indicated for active immunization against diphtheria, tetanus, pertussis, and poliomyelitis as the fifth dose in the diphtheria, tetanus, and acellular pertussis (DTaP) vaccine series and the fourth dose in the inactivated poliovirus vaccine (IPV) series in children 4...Read more...

M2SR

FluGen’s M2SR vaccine utilizes a proprietary M2 deleted, single replication (M2SR) influenza virus.

The M2 gene is essential for the influenza virus to spread in the patient and the deletion of the M2 gene restricts the virus to a single replication cycle in the host.

The body...Read more...

mAb114 (Ebola)

 mAb114 is a single monoclonal antibody developed by NIAID.  

mAb114, a single monoclonal antibody, binds to the core receptor binding domain of the Zaire ebolavirus surface protein, preventing the virus from infecting human cells.

Two clinical trials are underway for this...Read more...

Menactra

Menactra vaccine is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. Menactra vaccine is approved for use in individuals 9 months through 55 years of age. Menactra vaccine does not prevent N meningitidis...Read more...

Menhibrix

MENHIBRIX is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b. MENHIBRIX is approved for use in children 6 weeks of age through 18 months of age.Read more...

Menveo

MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. MENVEO is approved for use in persons 2 months through 55 years of age. MENVEO does not prevent N. meningitidis serogroup B infections...Read more...

MMR II

M-M-R ® II is indicated for simultaneous vaccination against measles, mumps, and rubella in individuals 12 months of age or older.Read more...

Mosquirix (RTS,S)

Mosquirix is a vaccine that is given to children aged 6 weeks to 17 months to help protect against malaria caused by the parasite Plasmodium falciparum.

The vaccine should only be used in areas of the world where malaria caused by Plasmodium falciparum is prevalent, and according to...Read more...

mRNA-1653

mRNA-1653 is designed to protect against human metapneumovirus (hMPV) and parainfluenza type 3 (PIV3), two viruses that cause respiratory infections. 

It is a combination vaccine that consists of two distinct mRNA sequences encoding the fusion (F) proteins of hMPV and PIV3 formulated in...Read more...

NanoFlu - influenza

Novavax's NanoFlu is an influenza vaccine candidate in a phase 2 clinical study.

The trial compared the safety and immune responses of various quadrivalent formulations of NanoFlu, with or without Novavax’...Read more...

NeoVax

NeoVax is a personalized experimental vaccine designed to recognize cancer-specific proteins, called neoantigens, that are present on the individual’s cancer cells but not on normal cells.

The vaccine, known as NeoVax, is based on research at Dana-Farber led by Catherine Wu, M.D.  ...Read more...

Nexvax2 - Celiac Disease

Nexvax2 is being developed to protect celiac disease (CeD) patients who carry the HLA-DQ2.5 immune recognition genes, from inadvertent gluten exposure.

Patients with the HLA-DQ2.5 genes account for more than 90% of the CeD population.

A global...Read more...

PAMVAC

PAMVAC is a vaccine candidate based on a recombinant fragment of VAR2CSA, the Plasmodium falciparum protein responsible for binding to the placenta via chondroitin sulfate A (CSA).

PAMVAC was found safe during a ...Read more...

Pediarix

PEDIARIX is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis, infection caused by all known subtypes of hepatitis B virus, and poliomyelitis. PEDIARIX is approved for use as a three-dose series in infants born of hepatitis B surface antigen (HBsAg)-negative...Read more...

Pedvaxhib

PedvaxHIB is indicated for routine vaccination against invasive disease caused by Haemophilus influenzae type b in infants and children 2 to 71 months of age. PedvaxHIB should not be used in infants <6 weeks of age.Read more...

PennVax-GP

PENNVAX®-GP is a developmental vaccine to prevent and treat HIV strains primarily present in Africa, Asia, Europe, and North America. It is intended to induce broad antibody and T-cell immune responses. This multi-subtype vaccine is based on optimized synthetic immunogens targeting two env...Read more...

Pentacel

Pentacel vaccine is indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis, and invasive disease due to H influenzae type b. Pentacel vaccine is approved for use as a 4-dose series in children 6 weeks through 4 years of age (prior to the fifth birthday).Read more...

Pneumovax 23

PNEUMOVAX ® 23 (Pneumococcal Vaccine Polyvalent) is a vaccine indicated for active immunization for the prevention of pneumococcal disease caused by the 23 serotypes contained in the vaccine (1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19F, 19A, 20, 22F, 23F, and 33F)....Read more...

Prevnar 13

Prevnar 13® is a vaccine indicated in children 6 weeks through 17 years (prior to the 18th birthday) for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F, and for children 6 weeks...Read more...

Proquad

ProQuad is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12 years of age.Read more...

PRV-101 (Type 1 Diabetes)

PRV-101 is a polyvalent coxsackievirus B (CVB) vaccine licensed from Vactech, Ltd., which Provention is developing as a potential vaccine for acute coxsackie infection and for the potential prevention of up to 50% of worldwide type 1 diabetes (T1D) cases.

PRV-101 is currently in an IND-...Read more...

Quadracel

Quadracel vaccine is indicated for active immunization against diphtheria, tetanus, pertussis, and poliomyelitis. A single dose of Quadracel vaccine is approved for use in children 4 through 6 years of age as a fifth dose in the diphtheria, tetanus, pertussis vaccination (DTaP) series, and as a...Read more...

Rabavert

RABAVERT is indicated for preexposure vaccination, in both primary series and booster dose, and for postexposure prophylaxis against rabies in all age groups.Read more...

Recombivax HB

RECOMBIVAX HB is indicated for prevention of infection caused by all known subtypes of hepatitis B virus. RECOMBIVAX HB is approved for use in individuals of all ages. RECOMBIVAX HB Dialysis Formulation is approved for use in adult predialysis and dialysis patients 18 years of age and older.Read more...

RiVax®

RiVax® is Soligenix’s proprietary vaccine developed to protect against exposure to ricin toxin and is the most advanced vaccine product in the company’s portfolio.

With RiVax®, Soligenix is a world leader in ricin toxin vaccine research.

The immunogen in RiVax® induces a protective...Read more...

Rotarix

ROTARIX is a vaccine indicated for the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9) when administered as a 2-dose series. ROTARIX is approved for use in infants 6 weeks to 24 weeks of age.Read more...

Rotateq

RotaTeq is indicated for the prevention of rotavirus gastroenteritis in infants and children caused by Types G1, G2, G3, G4, and G9 when administered as a 3-dose series to infants between the ages of 6 to 32 weeks. The first dose of RotaTeq should be administered between 6 and 12 weeks of age....Read more...

scMAYV-E (Mayaro Virus)

The scMAYV-E DNA vaccine was administered to mice by intramuscular injection followed by pulses of electricity designed to make cells more permeable to foreign DNA and enhance vaccine uptake, which allows for dose-sparing.

Immunization with scMAYV-E induced robust MAYV-specific immune...Read more...

Shingrix

SHINGRIX is an FDA-approved vaccine for the prevention of shingles (herpes zoster) in adults 50 years and older. SHINGRIX is not used to prevent chickenpox.Read more...

Stamaril

Sanofi Pasteur confirms that YF-VAX® (Yellow Fever Vaccine) is unavailable to order in the U.S. until mid-2018 as the company transitions production to a new state-of-the-art facility, which is expected to occur in 2018. Sanofi Pasteur has worked with the FDA to make another yellow fever vaccine...Read more...

Trumenba

Trumenba is a vaccine indicated for individuals 10 through 25 years of age for active immunization to prevent invasive disease caused by Neisseria meningitidis group B The effectiveness of the two-dose schedule of Trumenba against diverse N meningitidis serogroup B strains has not been confirmed...Read more...

Truvada

TRUVADA for PrEP (pre-exposure prophylaxis) is a prescription medicine that is used together with safer sex practices to help reduce the risk of getting HIV-1 through sex. This use is only for HIV-negative adults who are at high risk of getting HIV-1. To help determine your risk of getting HIV-1...Read more...

Twinrix

TWINRIX is a vaccine indicated for active immunization against disease caused by hepatitis A virus and infection by all known subtypes of hepatitis B virus. TWINRIX is approved for use in persons 18 years of age or older.Read more...

Typhim VI

TYPHIM Vi is manufactured by Sanofi Pasteur for intramuscular use for protection against Typhoid Fever. It is a sterile solution, prepared from the purified polysaccharide capsule of Salmonella typhi (Ty 2 strain). The purified polysaccharide capsule is diluted in isotonic buffer solution which...Read more...

UB-311

UB-311, a novel synthetic peptide vaccine targeting beta amyloid (Aβ) in the treatment of Alzheimer's disease.

Currently completed a Phase 2a clinical trial study.  

The top-line Phase 2a data met the...Read more...

V920 (rVSV∆G-ZEBOV-GP) - Ebola

Merck's V920  (rVSVΔG-ZEBOV-GP)  candidate vaccine is a prime/boost candidate vaccine based on Ad26- and MVA-vectored components (Ad26.ZEBOV/MVA-BN-Filo) and the Ad5-EBOV candidate vaccine.

This...Read more...

Vaqta

VAQTA is indicated for the prevention of disease caused by hepatitis A virus (HAV) in persons 12 months of age and older. The primary dose should be given at least 2 weeks prior to expected exposure to HAV.Read more...

Varivax

VARIVAX is a vaccine indicated for active immunization for the prevention of varicella (ChickenPox) in individuals 12 months of age or older. Each dose is approximately 0.5 mL after reconstitution and is administered by subcutaneous injection.Read more...

Varizig

VARIZIG [Varicella Zoster Immune Globulin (Human)] is indicated in the United States for post-exposure prophylaxis of varicella (chickenpox) in high risk patient groups including immunocompromised children, newborns, and pregnant women. VARIZIG is intended to reduce the severity of chickenpox...Read more...

Vaxchora

Vaxchora is a vaccine indicated for active immunization against disease caused by Vibrio cholerae serogroup O1 in adults 18 through 64 years of age traveling to cholera-affected areas.Read more...

Vivotif

Vivotif is an oral vaccine for typhoid fever, a potentially severe and life-threatening infection caused by the bacterium Salmonella enterica serotype Typhi ( S Typhi). Taken orally, the vaccine is delivered to the mucosal surface of the gastrointestinal tract—the largest immunologic organ in...Read more...

VLA15-Lyme Disease

VLA15 is a multivalent vaccine that targets the outer surface protein A (OspA) of Borrelia and is under Fast Track Designation by the Food and Drug Administration (FDA). 

On December 17, 2018, Valneva SE announced the initiation of the ...Read more...

VLA1553 - Chikungunya Vaccine Candidate

Valneva initiated a Phase 1 clinical trial in the US to evaluate the safety and immunogenicity of VLA1553, its live-attenuated vaccine candidate against...Read more...

VXA‑G1.1-NN (Norovirus)

VXA-G1.1-NN is an Oral Vaccine Tablet addressing Norovirus.

The clinical trial is a Phase 1, Randomized, Double-Blind, Placebo-controlled, Dose-ranging Trial to Determine the Safety and Immunogenicity of an...Read more...

YF-VAX

YF-VAX is indicated for active immunization for the prevention of yellow fever in persons 9 months of age and older in the following categories: Persons Living in or Traveling to Endemic Areas, Persons Travelling Internationally Through Countries with Yellow Fever, Laboratory PersonnelRead more...

Zostavax

ZOSTAVAX is a single shot vaccine for adults 50 years of age or older that helps to boost the immune system against Shingles. ZOSTAVAX cannot be used to treat Shingles or the nerve pain that may follow Shingles, once you have it.Read more...